S100A8	S100A8 is a member of the S100 protein family with EF-hand calcium-binding motifs, involved in cellular processes like cell cycle and differentiation. Located on chromosome 1q21, it may inhibit casein kinase and function as a cytokine. Altered expression is linked to cystic fibrosis and associated with skin cancer in humans. Multiple transcript variants exist.
KRT6A	KRT6A is a keratin gene encoding type II cytokeratins, involved in epithelial differentiation. It pairs with KRT16/KRT17 in various tissues. Located on chromosome 12q12-q13, mutations link to pachyonychia congenita. C-terminal peptides have antimicrobial properties. Relevant to skin cancer research.
KRT14	KRT14 encodes type I keratin, part of epithelial cytoskeleton with keratin 5. Found in skin cells, mutations linked to epidermolysis bullosa simplex and skin cancer. Located at 17p12-p11 with known pseudogene. Important in cell structure and response to damage.
S100A9	S100A9 is part of the S100 family with EF-hand calcium-binding motifs, affecting cell cycle and differentiation. Located on chromosome 1q21, it may inhibit casein kinase and is linked to cystic fibrosis. S100A9 exhibits antimicrobial properties and its altered expression is associated with skin cancer.
KRT5	KRT5 encodes a type II cytokeratin protein expressed in the epidermis' basal layer, coexpressed with KRT14. Mutations can lead to epidermolysis bullosa simplex and increased skin cancer risk. Located on chromosome 12q12-q13, KRT5 belongs to the keratin gene family, crucial for epithelial tissue differentiation.
KRT6B	KRT6B encodes type II cytokeratin involved in epithelial tissue differentiation. Coexpressed with KRT16/KRT17 in oral mucosa, esophagus, and hair follicles. Mutations linked to pachyonychia congenita. Type II cytokeratins are located on chromosome 12q12-q13. Potential role in skin cancer due to its expression in epithelial tissues.
KRT16	KRT16 encodes a keratin protein in the epithelial cells, contributing to structural integrity. Located on chromosome 17q12-q21, it pairs with KRT14 in tissues like esophagus and hair follicles. Mutations link to pachyonychia congenita, non-epidermolytic palmoplantar keratoderma, and unilateral verrucous nevus. Research suggests a role in skin cancer pathogenesis.
KRT6C	KRT6C encodes a type II cytokeratin in epithelial tissues. It duplicates with KRT16/KRT17 and is linked to pachyonychia congenita. Located on chromosome 12q12-q13, its C-terminal peptides exhibit antimicrobial activity. Mutations may contribute to skin cancer pathogenesis by disrupting epithelial integrity.
KRT17	KRT17 encodes keratin 17, involved in skin appendages. Mutations are linked to skin disorders like pachyonychia congenita and steatocystoma multiplex. Also associated with skin cancer, influencing tumor growth and progression. Expressed in nail bed, hair follicles, sebaceous glands.
MT-CO3	MT-CO3 contributes to cytochrome-c oxidase activity, is involved in respiratory chain complex IV assembly, and is located in the mitochondrion. It is a part of the mitochondrial membrane and respiratory chain complex IV, and implicated in MELAS syndrome. Mutations may be related to skin cancer.
S100A7	S100A7 gene encodes a protein in the S100 family with EF-hand motifs, lacking calcium binding in one EF-hand. Localized in cytoplasm/nucleus, it regulates cell processes like cycle progression/differentiation. Overexpressed in hyperproliferative skin diseases, shows antimicrobial and immunomodulatory activities. Clustered with other S100 genes on chromosome 1q21.
MT-CO2	MT-CO2 is linked to cytochrome-c oxidase activity, facilitating mitochondrial electron transport from cytochrome c to oxygen. Located in the mitochondrial inner membrane and part of respiratory chain complex IV, MT-CO2 may influence vasoconstriction. It is a biomarker for Huntington's disease, stomach cancer, and potentially skin cancer. Involved in respiratory chain function.
SFN	SFN encodes a cell cycle checkpoint protein involved in mitotic translation regulation. It binds to translation initiation factors and addresses DNA damage by preventing errors during mitosis. Alterations in this gene are implicated in skin cancer development.
S100A2	S100A2 encodes a protein in the S100 family, with EF-hand calcium-binding motifs, involved in cell cycle regulation and differentiation. Located on chromosome 1q21, it may act as a tumor suppressor. Altered expression linked to skin and breast cancer.
MT-CO1	MT-CO1 is linked to cytochrome-c oxidase activity, aerobic respiration, and respiratory electron transport chain in mitochondria. Involved in positive regulation of vasoconstriction. Part of mitochondrial membrane and respiratory chain complex IV. Associated with human skin cancer due to its role in cell respiration and energy production.
ACTB	ACTB encodes a cytoskeletal actin protein involved in cell motility and integrity. Mutations can cause Baraitser-Winter syndrome 1, linked to intellectual disability. ACTB is ubiquitously expressed and related to skin cancer through its role in cellular signaling and structure. Numerous pseudogenes exist in the human genome.
PERP	PERP is associated with cysteine-type endopeptidase activation and neutrophil chemotaxis regulation. It is located in desmosomes and plasma membranes, active in cell-cell junctions. PERP is implicated in skin disorders, including erythrokeratodermia variabilis and palmoplantar keratoderma. Its role in skin cancer involves cell adhesion and apoptosis.
SPRR1B	SPRR1B encodes a keratinocyte envelope protein crosslinked by transglutaminase, forming an insoluble layer under the plasma membrane. It is proline-rich with tandem repeats. SPRR1B is implicated in skin cancer due to its role in keratinocyte differentiation and barrier formation.
KRT10	KRT10 encodes type I cytokeratin in intermediate filament proteins. Keratins are structural proteins forming intermediate filaments, part of epithelial cell cytoskeleton. Mutations lead to epidermolytic hyperkeratosis. Located on chromosome 17q21 in keratin cluster. Associated with skin cancer due to its role in maintaining skin integrity and cell structure.
KRT1	KRT1 encodes a type II cytokeratin protein in the keratin gene family, coexpressed with KRT10 during epithelial differentiation. It is expressed in the spinous and granular layers of the epidermis. Mutations link to bullous congenital ichthyosiform erythroderma and may impact skin cancer pathways. Located on chromosome 12q12-q13.
EEF1A1	EEF1A1 encodes the alpha subunit of the elongation factor-1 complex, facilitating aminoacyl tRNA delivery to ribosomes. It is expressed in brain, placenta, lung, liver, kidney, and pancreas. EEF1A1 is an autoantigen in Felty syndrome and has multiple pseudogene copies. It is implicated in skin cancer through its role in protein synthesis and cellular proliferation.
RPLP1	RPLP1 encodes a ribosomal phosphoprotein part of the 60S subunit, involved in protein synthesis elongation. It is acidic, interacts with P0 and P2 to form a pentameric complex, and is located in the cytoplasm. Multiple processed pseudogenes exist. It is associated with skin cancer in humans.
LGALS7B	LGALS7B encodes a galectin protein involved in cell-cell and cell-matrix interactions. Expressed in keratinocytes, it is located in stratified squamous epithelium. This gene is linked to skin cancer due to its role in cellular adhesion processes. A duplicate gene exists nearby on chromosome 19, opposite strand. Research suggests potential implications in tumorigenesis through modulation of cellular environments.
LGALS7	LGALS7 encodes a beta-galactoside-binding protein involved in cell-cell and cell-matrix interactions, primarily expressed in keratinocytes of stratified squamous epithelium. It is related to skin cancer development. A duplicate gene is located on chromosome 19, opposite strand. Galectins influence cell adhesion, migration, and immune response, relevant to cancer pathology.
COL1A1	COL1A1 encodes type I collagen's pro-alpha1 chains. Mutations link to osteogenesis imperfecta and Ehlers-Danlos syndromes. Translocations with chromosome 22 associate with dermatofibrosarcoma protuberans, a skin tumor. Type I collagen is in connective tissues, bone, cornea, dermis, and tendon. Two transcripts exist due to alternate polyadenylation signals.
FABP5	FABP5 encodes fatty acid binding protein in epidermal cells, linked to psoriasis. Involved in fatty acid uptake, transport, and metabolism. Polymorphisms associated with type 2 diabetes. Implicated in skin cancer development through altered lipid metabolism. Contains pseudogenes similar to its locus.
RPS12	RPS12 encodes a ribosomal protein part of the 40S subunit, located in the cytoplasm and linked to protein synthesis. It's part of the S12E family. Increased expression noted in colorectal cancers. Multiple processed pseudogenes exist across the genome. Potential link to skin cancer due to its role in cell growth and protein synthesis regulation.
HLA-B	HLA-B is part of the HLA class I molecules, consisting of a heavy chain and beta-2 microglobulin. It presents peptides from the endoplasmic reticulum lumen, crucial for immune response. Expressed in most cells, its gene has 8 exons. Exons 2 and 3 determine peptide binding specificity. Polymorphisms are important for transplantation. Hundreds of alleles exist. Linked to skin cancer susceptibility.
MT-ND4	MT-ND4 is involved in mitochondrial electron transport and respiratory chain complex I assembly. It is linked to skin cancer, Leber hereditary optic neuropathy, Parkinson's disease, macular degeneration, schizophrenia, and Alzheimer's disease. The gene enables NADH dehydrogenase activity and is located in the mitochondrial inner membrane.
RPLP2	RPLP2 encodes a ribosomal phosphoprotein in the 60S subunit, analogous to E. coli L7/L12, part of the L12P family. It aids protein synthesis elongation, forming a pentameric complex with P0 and P1. Uniquely acidic, RPLP2 has multiple pseudogenes. Implicated in skin cancer, it may influence ribosomal function and cellular growth pathways, contributing to oncogenesis.
ACTG1	ACTG1 encodes cytoplasmic actin gamma 1, involved in cell motility and cytoskeleton maintenance. Found in all cell types, it's linked to skin cancer risk. Mutations are associated with DFNA20/26 hearing loss and Baraitser-Winter syndrome. Alternative splicing produces multiple transcripts.
GJB2	GJB2 encodes a gap junction protein, connexin 26, facilitating ion and molecule transfer between cells. Mutations are linked to pre-lingual, recessive deafness and implicated in skin cancer. Gap junctions are cell-to-cell channels, with connexins classified into alpha and beta based on sequence similarity. GJB2 mutations may affect intercellular communication, contributing to tumorigenesis in skin cancer.
B2M	B2M is associated with MHC class I on nearly all nucleated cells. It forms beta-pleated sheets and can create amyloid fibrils. It exhibits antibacterial activity in amniotic fluid. Mutations can lead to hypercatabolic hypoproteinemia. B2M is implicated in immune response and has a potential link to skin cancer through altered cell surface expression affecting immune surveillance.
TPT1	TPT1 encodes a protein regulating cellular growth, proliferation, apoptosis, protein synthesis, and cell division. It stabilizes microtubules, necessary for mitotic and meiotic progression. TPT1 is upregulated in certain cancers, including skin cancer, contributing to carcinogenesis. Its mRNA features an oligopyrimidine tract repressing translation in quiescent states. The gene undergoes alternative splicing, producing various isoforms.
RPL13	RPL13 encodes a ribosomal protein part of the 60S subunit, located in the cytoplasm. It belongs to the L13E family and has alternatively spliced variants. RPL13 exhibits higher expression in benign breast lesions versus carcinomas. There are multiple pseudogenes dispersed through the genome. The role of RPL13 in skin cancer involves its function in protein synthesis and cellular growth regulation.
MT-ATP6	MT-ATP6 is involved in mitochondrial ATP synthesis via proton transport. Located in mitochondrion, part of ATP synthase complex. Associated with Leber hereditary optic neuropathy, NARP syndrome, Parkinson's disease, multiple sclerosis, systemic lupus erythematosus, and skin cancer.
RPS24	RPS24 encodes a protein in the 40S ribosomal subunit, located in the cytoplasm. It belongs to the S24E family and has multiple transcript variants. Mutations are linked to Diamond-Blackfan anemia and implicated in skin cancer.
PFN1	PFN1 encodes an actin-binding protein involved in actin polymerization regulation. It is linked to Miller-Dieker syndrome and may influence Huntington disease. Multiple pseudogenes are on chromosome 1. PFN1 is associated with skin cancer through its role in cytoskeletal dynamics.
KRTDAP	KRTDAP gene encodes a protein involved in keratinocyte differentiation and maintenance of stratified epithelia. It has multiple transcript variants and isoforms. Potential associations with skin cancer through epithelial regulation are under investigation.
RPS6	RPS6 encodes a ribosomal protein part of the 40S subunit, involved in protein synthesis. It is phosphorylated by various protein kinases, regulated by stimuli like growth factors and mitogens. Phosphorylation affects cell growth and mRNA translation, linking RPS6 to skin cancer mechanisms. Multiple pseudogenes exist in the genome.
DMKN	DMKN is upregulated in inflammatory diseases and expressed in differentiated skin layers. It uses different promoters and terminators for isoform diversity, affecting cellular distribution and domain composition. DMKN's alternative splicing leads to various transcript variants. Its role in skin cancer is associated with altered expression patterns and potential contribution to tumorigenesis.
RPLP0	RPLP0 encodes a ribosomal protein of the 60S subunit, part of protein synthesis machinery. It forms a pentamer with P1 and P2 proteins, and is part of the L10P family. Located in the cytoplasm, it has multiple pseudogenes. Alternative splicing occurs without altering the protein. It is linked to skin cancer.
MT-ND3	MT-ND3 is involved in mitochondrial electron transport as part of complex I, facilitating NADH to ubiquinone conversion. Located in the mitochondrial inner membrane, it is linked to Leber hereditary optic neuropathy, Leigh disease, Parkinson's disease, and skin cancer due to its role in oxidative phosphorylation and reactive oxygen species production.
RPL37A	RPL37A encodes a ribosomal protein in the 60S subunit, part of the L37AE family, with a C4-type zinc finger-like domain. It is located in the cytoplasm. The protein is involved in protein synthesis and has multiple pseudogenes. Alterations in ribosomal proteins like RPL37A are linked to skin cancer in humans, affecting cellular growth and proliferation.
DSP	The DSP gene encodes a protein anchoring intermediate filaments to desmosomal plaques, essential for desmosome function. Mutations cause cardiomyopathies, keratodermas, and skin conditions like skin fragility-woolly hair syndrome. It is implicated in skin cancer due to its role in cell adhesion and structural integrity. Alternative splicing creates multiple transcripts, impacting protein function and disease manifestation.
CXCL14	CXCL14 is a cytokine gene linked to skin cancer, encoding proteins in immunoregulatory and inflammatory processes. Related to CXC cytokines, it is chemotactic for monocytes, involved in monocyte-derived macrophage homeostasis, not inflammation. It plays roles in antimicrobial activity and immune response regulation.
RPS18	RPS18 encodes a protein in the 40S ribosomal subunit, essential for protein synthesis. It's involved in translation initiation by binding fMet-tRNA. Multiple pseudogenes exist. RPS18's role in ribosome function links it to cellular mechanisms potentially impacting skin cancer development.
RPS17	RPS17 encodes a ribosomal protein in the 40S subunit, part of the S17E family. It plays a role in protein synthesis in the cytoplasm. Mutations can cause Diamond-Blackfan anemia 4. Alternative splicing leads to multiple variants. There are many pseudogenes across the genome. Linked to skin cancer in humans.
RPS8	RPS8 encodes a protein in the 40S ribosomal subunit, part of the S8E family. Located in the cytoplasm, it shows increased expression in colorectal tumors. Co-transcribed with small nucleolar RNA genes U38A, U38B, U39, and U40. Multiple pseudogenes exist. Potential relevance to skin cancer due to its role in protein synthesis and observed expression changes in other cancers.
RPL13A	RPL13A encodes a protein in the 60S ribosomal subunit, involved in protein synthesis and repression of inflammatory genes via the GAIT complex. It is co-transcribed with snoRNA genes in introns and has multiple pseudogenes across the genome. Alternative splicing produces various isoforms. Linked to skin cancer through its role in immune response regulation.
MT-CYB	MT-CYB is involved in mitochondrial electron transport, aiding in ubiquinol-cytochrome-c reductase activity. Located in the mitochondrial inner membrane, it contributes to metal ion binding. Associations with ovarian carcinoma, urinary bladder cancer, and skin cancer have been noted.
RPL11	RPL11 encodes a ribosomal protein in the 60S subunit, part of the L5P family, located in cytoplasm, associated with 5S rRNA. Involved in protein synthesis, skin cancer through ribosome biogenesis disruption. Multiple processed pseudogenes exist. Variants encode different isoforms.
RPL27A	RPL27A encodes a ribosomal protein part of the 60S subunit, involved in protein synthesis. Located in the cytoplasm, it belongs to the L15P family. Expression variation is noted in colorectal cancer tissues without disease severity correlation. Multiple pseudogenes exist across the genome. Research on its role in skin cancer is ongoing.
RPL28	RPL28 encodes a ribosomal protein in the 60S subunit, part of the L28E family, found in the cytoplasm. It shows variable expression in colorectal cancers. Multiple pseudogenes exist across the genome, and alternative splicing yields various isoforms. Its role in skin cancer remains to be further explored.
MT-ND1	MT-ND1 encodes NADH dehydrogenase, involved in electron transport and complex I assembly in mitochondria. Located in the inner membrane, it is associated with MELAS syndrome, neurodegenerative and optic nerve diseases, toxic shock syndrome, type 2 diabetes, Alzheimer's, Parkinson's, and multiple sclerosis. Related to skin cancer in humans.
RPS27	RPS27 encodes a protein in the 40S ribosomal subunit with a C4-type zinc finger domain. Mutations are linked to melanoma and Diamond-Blackfan anemia. Elevated expression is noted in various cancers. Multiple pseudogenes exist across the genome.
RPL32	RPL32 encodes a ribosomal protein of the 60S subunit, located in the cytoplasm. It maps to 3p25-p24 and belongs to the L32E family. Multiple pseudogenes exist throughout the genome, with alternatively spliced variants observed. Involvement in skin cancer is suggested by its role in protein synthesis, impacting cellular processes and potentially influencing tumorigenesis.
CSTA	CSTA encodes a stefin involved in cysteine protease inhibition, forming complexes with papain and cathepsins B, H, L. It contributes to epidermal development and maintenance as a precursor in cornified cell envelope. Stefins are proposed as prognostic and diagnostic tools for cancer, including skin cancer.
RPL34	RPL34 encodes a ribosomal protein part of the 60S subunit, located in the cytoplasm. Mapped to chromosome 4q, it is overexpressed in some cancer cells, including skin cancer. It belongs to the L34E family, with multiple transcript variants and pseudogenes across the genome. Associated with protein synthesis, its dysregulation is linked to oncogenesis in skin cancer.
RPL31	RPL31 encodes a ribosomal protein part of the 60S subunit, located in the cytoplasm. It belongs to the L31E family. Higher expression levels observed in familial adenomatous polyps may suggest involvement in skin cancer. Multiple pseudogenes and alternatively spliced isoforms exist.
COL1A2	COL1A2 encodes pro-alpha2 chain of type I collagen, part of connective tissue. Mutations linked to osteogenesis imperfecta, Ehlers-Danlos syndrome, idiopathic osteoporosis, atypical Marfan syndrome. Less severe than COL1A1 mutations due to different matrix roles. Three transcripts identified via alternate polyadenylation signals.
RPL8	RPL8 encodes a ribosomal protein in the 60S subunit, part of the L2P family. It interacts with 5.8S rRNA and aminoacyl-tRNA, contributing to elongation factor 2 binding. Located in the cytoplasm, RPL8 has multiple pseudogenes. It may be involved in skin cancer pathogenesis through protein synthesis dysregulation.
SBSN	SBSN is involved in skin cancer. It is found in extracellular exosome, suggesting a role in cell signaling or communication processes. SBSN may influence tumor microenvironment or metastasis in skin cancer. Further research may explore its function in cancer progression and potential as a biomarker or therapeutic target.
TMSB10	TMSB10 is linked to skin cancer in humans. It facilitates actin monomer binding, regulating cell migration and actin monomer sequestration. It resides in the cytoskeleton and cytoplasm. Its role in actin dynamics may impact cellular processes involved in tumorigenesis.
ENO1	ENO1 encodes alpha-enolase, a glycolytic enzyme and structural lens protein. Alternative splicing produces a shorter isoform binding to c-myc promoter as a tumor suppressor. ENO1 is linked to skin cancer, with pseudogenes on chromosome 1. It also acts as an autoantigen in Hashimoto encephalopathy.
RPS14	RPS14 encodes a ribosomal protein part of the 40S subunit, involved in protein synthesis. Located in the cytoplasm, it belongs to the S11P family. Mutations in RPS14 are associated with resistance to protein synthesis inhibitors. Variants exist due to alternative transcription. It may play a role in skin cancer, as ribosomal dysfunction can affect cell proliferation and apoptosis.
RPL36	RPL36 encodes a ribosomal protein in the 60S subunit, part of the L36E family. It plays a role in protein synthesis, with transcript variants from alternative splicing encoding the same protein. Multiple pseudogenes are dispersed in the genome. RPL36 is linked to skin cancer, potentially affecting ribosome function and protein synthesis in cancer cells.
SPRR2A	SPRR2A gene involved in skin cancer; lipid binding activity; antibacterial humoral response; defense against Gram-positive bacteria; located in cytoplasm, active in extracellular region and secretory granule.
RPL39	RPL39 encodes a ribosomal protein part of the 60S subunit, involved in protein synthesis. Located in the cytoplasm, co-transcribed with U69 RNA in its second intron. Multiple pseudogenes exist. Implicated in skin cancer through its role in ribosome function and protein synthesis regulation.
GSTP1	GSTP1 encodes glutathione S-transferase pi, involved in detoxification by conjugating compounds with glutathione. It is a polymorphic gene with variant proteins affecting xenobiotic metabolism. GSTP1 variants are linked to susceptibility to skin cancer and other diseases.
RPS27A	RPS27A encodes a fusion protein of ubiquitin and ribosomal protein S27a, part of the 40S ribosomal subunit. Ubiquitin targets proteins for degradation. RPS27A involves C4-type zinc finger domains and cytoplasmic location. Pseudogenes exist. Alternative splicing occurs. S27a may link to skin cancer via protein degradation and ribosomal function affecting cell cycle and growth.
JUP	JUP encodes a cytoplasmic protein part of submembranous plaques in desmosomes and junctions, forming complexes with cadherins. It belongs to the catenin family with armadillo repeats. Mutations link to Naxos disease. Alternative splicing exists, with incomplete transcript descriptions. Involved in skin cancer processes.
RPS19	RPS19 encodes a ribosomal protein part of the 40S subunit, linked to Diamond-Blackfan anemia. It may have a role in erythropoietic differentiation. Overexpression observed in colon carcinomas. Multiple pseudogenes exist. Potential involvement in skin cancer due to similar expression patterns in malignant tissues.
RPL37	RPL37 encodes a ribosomal protein in the 60S subunit, part of the L37E family, featuring a C2C2-type zinc finger-like motif. It's located in the cytoplasm and linked to multiple processed pseudogenes. RPL37 is associated with skin cancer, contributing to protein synthesis regulation.
RPL27	RPL27 encodes a ribosomal protein part of the 60S subunit, involved in protein synthesis. Mutations in RPL27 are linked to Diamond-Blackfan anemia. It has multiple pseudogenes dispersed in the genome. RPL27 may have implications in skin cancer due to its role in cellular growth and protein production.
RPL3	RPL3 encodes a ribosomal protein of the 60S subunit, involved in protein synthesis. Located in the cytoplasm, it binds HIV-1 TAR mRNA, influencing tat-mediated transactivation. Co-transcribed with small nucleolar RNA genes, it has splice variants and pseudogenes. Linked to skin cancer, RPL3's dysregulation affects cellular growth and repair mechanisms.
RPS29	RPS29 encodes a protein in the 40S ribosomal subunit, part of the S14P family, with a zinc finger-like domain enhancing KREV1 tumor suppressor activity. It shows variable expression in colorectal cancer without disease severity correlation. Located in the cytoplasm, it has multiple pseudogenes and spliced variants. Related to skin cancer.
COL3A1	COL3A1 encodes the pro-alpha1 chains of type III collagen, present in extensible connective tissues like skin and associated with type I collagen. Mutations link to Ehlers-Danlos syndrome type IV, aortic, and arterial aneurysms. In skin, these mutations may contribute to cancer development by affecting collagen's structural role.
RPS11	RPS11 encodes a ribosomal protein part of the 40S subunit, co-transcribed with snoRNA gene U35B. Involved in protein synthesis, it has multiple pseudogenes in the genome. Linked to skin cancer, alterations may affect ribosome function and cellular proliferation.
CSTB	CSTB encodes an intracellular thiol protease inhibitor involved in cysteine protease inhibition. It forms dimers to inhibit proteases like papain and cathepsins. CSTB mutations, notably promoter expansions, are linked to progressive myoclonic epilepsy (EPM1). Its role in skin cancer may involve protease regulation affecting cellular pathways or lysosomal function.
RPL9	RPL9 encodes a ribosomal protein of the 60S subunit, part of the L6P family, located in the cytoplasm. This protein is involved in protein synthesis. The gene has multiple processed pseudogenes and alternative splicing results in various transcript variants. RPL9 is implicated in skin cancer.
RACK1	RACK1 is involved in cyclin, enzyme, and protein domain specific binding activities. It regulates protein metabolism, signal transduction, and vesicle-mediated transport. Located in the midbody, perinuclear cytoplasm, and phagocytic cup, it is part of the IRE1-RACK1-PP2A complex. Associated with skin cancer in humans.
ANXA2	ANXA2 encodes annexin family member involved in calcium-dependent phospholipid binding, cellular growth regulation, and signal transduction. Functions as autocrine factor in osteoclast formation and bone resorption. Expression correlates with treatment resistance in cancers. Three pseudogenes on chromosomes 4, 9, 10. Multiple transcript variants with different isoforms exist.
RPL7A	RPL7A encodes a ribosomal protein in the 60S subunit of cytoplasmic ribosomes. It interacts with nuclear hormone receptors, inhibiting their DNA binding. RPL7A gene is part of the surfeit gene cluster, co-transcribed with several small nucleolar RNA genes. It can rearrange with the trk proto-oncogene to form the oncogenic trk-2h, relevant for skin cancer studies. Processed pseudogenes of RPL7A are dispersed in the genome.
RPL23	RPL23 encodes a ribosomal protein of the 60S subunit, belonging to the L14P family. It shares amino acid identity with yeast L17 protein. Located in the cytoplasm, RPL23 is linked to skin cancer. Multiple pseudogenes exist in the genome.
RPL19	RPL19 encodes a ribosomal protein in the 60S subunit, part of the L19E family. It is located in the cytoplasm and involved in protein synthesis. Multiple pseudogenes exist for this gene. RPL19 has been studied in relation to skin cancer, focusing on its role in ribosome function and protein synthesis disruption.
S100A11	S100A11 is involved in cell cycle regulation, apoptosis, and differentiation. It is a member of the S100 protein family and plays a role in calcium binding. S100A11 is associated with skin cancer, influencing tumor progression and metastasis. Its expression is altered in various cancers, including non-melanoma skin cancer. Research suggests that S100A11 may participate in cellular responses to environmental stress and may serve as a potential biomarker for skin cancer diagnosis.
RPS2	RPS2 encodes a ribosomal protein in the 40S subunit involved in protein synthesis. It belongs to the S5P family and is located in the cytoplasm. RPS2 is co-transcribed with small nucleolar RNA gene U64. Multiple processed pseudogenes exist. It shares sequence similarity with mouse LLRep3 and may be implicated in skin cancer research due to its role in cell proliferation and protein synthesis.
RPS28	RPS28 encodes a 40S ribosomal subunit protein, part of the S28E family, located in the cytoplasm. It is vital for protein synthesis. Multiple pseudogenes exist across the genome. Associated with skin cancer research in humans.
EEF2	EEF2 encodes a GTP-binding elongation factor essential for protein synthesis. It facilitates ribosomal translocation during translation and is inactivated by EF-2 kinase phosphorylation. EEF2's role in protein synthesis links it to cellular growth and division, implicating it in skin cancer development. Mutations or dysregulation of EEF2 may contribute to cancer progression by affecting protein synthesis and cell cycle control.
ANXA1	ANXA1 encodes a membrane protein binding phospholipids, inhibiting phospholipase A2, and possessing anti-inflammatory activity. Loss of ANXA1 function or expression is observed in multiple tumors, including skin cancer. ANXA1 may play a role in tumorigenesis and cancer progression.
CD74	CD74 encodes a protein involved in antigen presentation with MHC class II, acts as a receptor for MIF to trigger cell survival and proliferation, and interacts with APP to reduce amyloid beta production. It may have implications in skin cancer through immune regulation and cell proliferation pathways. Multiple spliced variants exist.
PABPC1	PABPC1 encodes poly(A) binding protein involved in mRNA regulation. It shuttles between nucleus and cytoplasm, binds 3' poly(A) tails, promotes ribosome recruitment, translation initiation, and poly(A) shortening for mRNA decay. Part of a small gene family with related pseudogenes, PABPC1 is linked to skin cancer.
LDHA	LDHA encodes lactate dehydrogenase A, catalyzing pyruvate to lactate conversion in anaerobic glycolysis. Predominantly in skeletal muscle, it influences energy production. Mutations link to exertional myoglobinuria. LDHA's role in metabolic reprogramming may impact skin cancer progression. The human genome includes non-transcribed pseudogenes of LDHA.
RPS3	RPS3 encodes a protein in the 40S ribosomal subunit, involved in protein synthesis initiation and UV-induced DNA repair. It is expressed in colon adenocarcinomas, adenomatous polyps, and co-transcribed with snoRNA genes U15A and U15B. Located in cytoplasm and nucleus, it has alternatively spliced variants and multiple pseudogenes.
RPL35A	RPL35A encodes a ribosomal protein part of the 60S subunit, located in the cytoplasm. It belongs to the L35AE family and binds initiator and elongator tRNAs. Originally mapped to chromosome 18, it is at 3q29-qter. It has multiple transcript variants due to alternative splicing. Associated with skin cancer, it has dispersed pseudogenes in the genome.
DSC2	DSC2 encodes a desmocollin protein, part of the desmosome structure, crucial for cell adhesion. Located on chromosome 18, it is linked to arrhythmogenic right ventricular dysplasia-11. Reduced DSC2 expression is observed in various cancers, including skin cancer. Alternative splicing produces multiple transcripts.
AQP3	AQP3 encodes aquaporin 3, involved in water and solute transport, including glycerol. It is expressed in skin cells and may influence skin cancer development by affecting hydration and cellular processes. Variants arise from alternative splicing.
RPS25	RPS25 encodes a ribosomal protein in the 40S subunit, part of the S25E family. It is cytoplasmic and has multiple pseudogenes across the genome. RPS25 is linked to protein synthesis and has implications in human skin cancer, possibly affecting cellular growth and repair mechanisms.
IFI27	IFI27 is involved in RNA polymerase II-specific transcription factor binding, identical protein binding, and lamin binding. It participates in defense response to symbionts, K48-linked ubiquitination, and pyroptotic inflammatory response. Functions in negative regulation of transcription by RNA polymerase II and protein export regulation from the nucleus. Found in mitochondrial and nuclear inner membranes, active in mitochondria, related to skin cancer.
CALML5	CALML5 encodes a calcium-binding protein in the epidermis, related to calmodulin. It binds calcium, changes conformation, and is abundant in differentiating keratinocytes. CALML5 associates with transglutaminase 3, crucial for keratinocyte terminal differentiation and potentially linked to skin cancer.
YWHAZ	YWHAZ encodes a member of the 14-3-3 protein family, involved in signal transduction through phosphoserine binding. Highly conserved, it interacts with IRS1, possibly affecting insulin sensitivity. Transcript variants exist. Associated with skin cancer risk due to its role in cell cycle regulation and apoptosis.
RPL6	RPL6 encodes a 60S ribosomal subunit protein involved in tax-mediated transcription in HTLV-1. It has pseudogenes and multiple transcript variants. RPL6 is linked to skin cancer development by influencing ribosomal biogenesis and cellular stress responses.
TMSB4X	TMSB4X encodes an actin-sequestering protein involved in actin polymerization, cell proliferation, migration, and differentiation. It is associated with skin cancer due to its role in cell behavior. This gene escapes X inactivation and has a Y chromosome homolog.
RPS23	RPS23 encodes a ribosomal protein part of the 40S subunit, involved in protein synthesis. It's located in the cytoplasm, belongs to the S12P family, and has similarity to S. cerevisiae protein S28. Multiple pseudogenes exist. Studies link RPS23 to skin cancer due to its role in cell growth and proliferation.
RPL12	RPL12 encodes a ribosomal protein in the 60S subunit, binding 26S rRNA. It is co-transcribed with U65 snoRNA in its fourth intron. RPL12 is linked to skin cancer due to its role in protein synthesis regulation and ribosome function. Multiple pseudogenes exist in the genome.
S100A14	S100A14 encodes a protein in the S100 family with an EF-hand motif for calcium binding. Located on chromosome 1, its protein levels are reduced in cancer tissues and linked to metastasis, suggesting a tumor suppressor role in skin cancer.
RPS4X	RPS4X encodes ribosomal protein S4, part of the 40S ribosome subunit, involved in protein synthesis. It is not X-inactivated and has functional equivalence with RPS4Y. RPS4X may be linked to Turner syndrome. The gene has multiple pseudogenes. Its role in skin cancer may involve protein synthesis regulation and cellular growth pathways.
UBA52	UBA52 encodes a ubiquitin and ribosomal protein L40 fusion. Ubiquitin targets proteins for degradation, maintains chromatin structure, regulates gene expression, and responds to stress. UBA52 is associated with multiple pseudogenes in the genome. It's implicated in skin cancer due to its role in protein regulation and stress response mechanisms.
SLPI	SLPI gene encodes a secreted inhibitor that protects epithelial tissues from serine proteases. It is present in secretions like seminal plasma and bronchial secretions. SLPI inhibits trypsin, leukocyte elastase, and cathepsin G, contributing to immune response by protecting epithelial surfaces. It exhibits antibacterial, antifungal, and antiviral activities and is implicated in skin cancer.
PKP1	PKP1 encodes a protein in the arm-repeat and plakophilin families, localizing to desmosomes and nuclei. It links cadherins to cytoskeletal intermediate filaments and aids in desmosome formation. Mutations associate with ectodermal dysplasia/skin fragility syndrome. Two transcript variants exist. PKP1 may be implicated in skin cancer due to its role in cell adhesion and stability.
RPL38	RPL38 encodes a ribosomal protein part of the 60S subunit, involved in protein synthesis in the cytoplasm. It's part of the L38E family, with alternative splice variants encoding the same protein. Associated pseudogenes exist, including one near the angiotensin II receptor gene's promoter. Research indicates a potential link to skin cancer.
HLA-A	HLA-A is part of HLA class I molecules, consisting of a heavy chain and beta-2 microglobulin. It presents peptides for cytotoxic T cell recognition, expressed in almost all cells. Polymorphisms in exon 2 and 3 affect peptide binding specificity, crucial for transplants. Over 6000 alleles exist. HLA-A influences immune response variability to infections, including malaria, HIV, SARS-CoV, and COVID-19, with multiple SARS-CoV-2 epitopes linked to HLA restrictions.
RPS13	RPS13 encodes a ribosomal protein in the 40S subunit, involved in protein synthesis. It belongs to the S15P family and is located in the cytoplasm. The protein binds 5.8S rRNA and functions in ribosome assembly. RPS13 co-transcribes with U14 small nucleolar RNAs. Multiple pseudogenes exist. Its role in skin cancer is under investigation.
LY6D	Involved in lymphocyte differentiation, located in extracellular region and plasma membrane, active on cell surface. Associated with skin cancer through its role in immune response regulation and cell signaling pathways.
RPL24	RPL24 encodes a ribosomal protein of the 60S subunit in cytoplasm, part of the L24E family. It's linked to protein synthesis and has pseudogenes across the genome. Studies suggest RPL24 involvement in skin cancer development, potentially through altered protein synthesis pathways.
ATP1B3	ATP1B3 encodes the beta 3 subunit of Na+/K+ ATPase, essential for ion gradients across the plasma membrane, crucial for osmoregulation, sodium-coupled transport, and electrical excitability. It consists of alpha and beta subunits, with the beta subunit regulating sodium pump assembly. ATP1B3 has a pseudogene on chromosome 2. Its role in ion transportation may impact cellular processes related to skin cancer.
MYL6	MYL6 encodes a myosin alkali light chain involved in ATPase activity, expressed in smooth muscle and non-muscle tissues. It has pseudogenes and two transcript variants with different isoforms. This gene may play a role in skin cancer through its involvement in cellular motor functions.
GJB6	GJB6 encodes a connexin protein forming gap junctions for ion/metabolite transport between cells. It involves six connexin proteins with four transmembrane segments. Mutations link to deafness and hidrotic ectodermal dysplasia. It may also be associated with skin cancer in humans.
S100A6	S100A6 is part of the S100 protein family, containing EF-hand calcium-binding motifs. Located on chromosome 1q21, it influences cell cycle, differentiation, insulin release, prolactin secretion, and exocytosis. Altered expression or chromosomal rearrangements of S100A6 are linked to melanoma, a form of skin cancer. S100 proteins are found in cytoplasm and nucleus across various cells, playing roles in cellular regulation.
HSPB1	HSPB1 encodes a heat shock protein involved in protein folding. It translocates to the nucleus under stress. Expression is linked to poor outcomes in various cancers, promoting proliferation and metastasis, and protecting cells from apoptosis. Mutations are associated with Charcot-Marie-Tooth disease and distal hereditary motor neuropathy.
RPL18	RPL18 encodes a protein part of the 60S ribosomal subunit involved in protein synthesis. It belongs to the L18E ribosomal protein family. Multiple pseudogenes exist, and alternative splicing results in various isoforms. RPL18 may have implications in skin cancer through its role in ribosomal function and protein synthesis regulation.
MT-ND2	Enables NADH dehydrogenase (ubiquinone) activity; involved in mitochondrial electron transport and respiratory chain complex I assembly. Located in mitochondrion. Associated with Leber hereditary optic neuropathy, multiple sclerosis, myocardial infarction, neurodegenerative diseases, urinary bladder cancer, and skin cancer.
SDC1	SDC1 encodes a transmembrane heparan sulfate proteoglycan in the syndecan family, involved in cell binding, signaling, and cytoskeletal organization. It facilitates HIV-1 tat protein internalization, and is integral in cell proliferation, migration, and interactions with extracellular matrix proteins. Altered expression is noted in various tumors, including skin cancer. Two major transcript variants encode the same protein.
IVL	Involucrin (IVL) is linked to the keratinocyte envelope, mapped to 1q21. It interacts with membrane proteins via transglutaminase. Associated with skin cancer through its role in cell envelope formation and differentiation.
FTL	FTL encodes the light subunit of ferritin, an intracellular iron storage protein. Composed of 24 heavy and light chains, ferritin stores iron in a soluble, nontoxic form. Variations affect iron uptake/release rates. Defects link to neurodegenerative diseases, hyperferritinemia-cataract syndrome. FTL may be involved in skin cancer through oxidative stress and iron metabolism disruption.
RPS3A	RPS3A encodes a ribosomal protein of the 40S subunit involved in protein synthesis. Located in the cytoplasm, associated with v-fos transformation in rats. Co-transcribed with U73A/B snoRNA genes. Multiple pseudogenes and alternatively spliced variants exist. Linked to skin cancer due to its role in protein synthesis and cell growth regulation.
RPL10	RPL10 encodes a ribosomal protein in the 60S subunit. It interacts with c-Jun, affecting transcriptional activation. Linked with autism spectrum disorders variably. Multiple pseudogenes exist. Alternative splicing produces diverse transcripts. Associated with skin cancer through gene expression alterations affecting cell growth and division.
RPS15A	RPS15A encodes a ribosomal protein part of the 40S subunit, involved in protein synthesis. It belongs to the S8P family and is cytoplasmic. Multiple pseudogenes exist. RPS15A has a role in cell proliferation and may be linked to skin cancer pathogenesis.
PI3	PI3 encodes an elastase-specific inhibitor with antimicrobial properties against bacteria and fungi, featuring a WFDC domain. Located in the centromeric cluster on chromosome 20q12-q13, its expression increases with bacterial lipopolysaccharides and cytokines. PI3 is studied in relation to skin cancer, potentially influencing tumor environment via immune modulation.
RPL18A	RPL18A encodes a 60S ribosomal subunit protein involved in protein synthesis. It may interact with hepatitis C virus IRES, influencing viral replication. Co-transcribed with U68 snoRNA, located in the third intron. Multiple pseudogenes exist. Related to skin cancer mechanism.
S100A10	S100A10 is part of the S100 protein family, featuring EF-hand calcium-binding motifs. Localized in the cytoplasm or nucleus, S100 proteins regulate cellular processes, including cell cycle progression and differentiation. S100A10 may play roles in exocytosis and endocytosis. S100 genes cluster on chromosome 1q21. Associated with skin cancer due to its involvement in cell regulation.
RPS7	RPS7 encodes a ribosomal protein in the 40S subunit, part of the S7E family, located in the cytoplasm. It has pseudogenes across the genome. RPS7's role in protein synthesis links to skin cancer, as ribosomal dysfunction can disrupt cellular processes and contribute to oncogenesis.
S100A7A	S100A7A is involved in protein binding and inflammatory response. Located in cytosol, it may have a role in skin cancer pathogenesis. S100 family proteins, including S100A7A, have been associated with tumor progression and metastasis. This gene's dysregulation is linked to skin cancer development, potentially affecting cellular stress responses and immune modulation in the epidermis.
RPL29	RPL29 encodes a cytoplasmic ribosomal protein of the 60S subunit, part of the L29E family. It binds heparin and is a peripheral membrane protein. Located at 3p21.3-p21.2, with pseudogenes dispersed in the genome. RPL29's role in protein synthesis may link to skin cancer pathogenesis.
RPL26	RPL26 encodes a ribosomal protein in the 60S subunit, part of the L24P family, located in the cytoplasm. It has multiple pseudogenes and transcript variants. Mutations are linked to Diamond-Blackfan anemia. Research suggests potential involvement in skin cancer due to its role in protein synthesis and cellular growth regulation.
RPL41	RPL41 is involved in mRNA 3'-UTR and 5'-UTR binding, influencing cytoplasmic translation. It is located in the endoplasmic reticulum and is a component of the cytosolic large ribosomal subunit. Its function relates to protein synthesis and may be implicated in skin cancer development.
RPL4	RPL4 encodes a protein in the 60S ribosomal subunit, part of the L4E family, located in the cytoplasm. It plays a role in protein synthesis. Multiple pseudogenes exist throughout the genome. RPL4 has been associated with skin cancer due to its involvement in cell proliferation and growth regulation.
RPL7	RPL7 encodes a ribosomal protein in the 60S subunit. It contains BZIP-like and RNP2 domains. RPL7 binds DNA/RNA and regulates translation. Located in cytoplasm, it acts as an autoantigen in systemic autoimmune diseases. Associated with skin cancer via protein synthesis disruption and cellular regulation. Multiple pseudogenes exist. Interacts preferentially with 28S rRNA and mRNA. Inhibits cell-free mRNA translation. Part of L30P ribosomal protein family.
SPARC	SPARC encodes a protein involved in extracellular matrix synthesis and cell shape changes. It plays roles in bone collagen calcification, tumor suppression, and metastasis. The gene has three transcript variants encoding different isoforms.
VIM	VIM encodes type III intermediate filament protein, crucial for cytoskeleton structure, cell shape, and cytoplasmic integrity. It organizes proteins related to cell attachment, migration, and signaling. Involved in neuritogenesis, cholesterol transport, and pathogen attachments. Mutations linked to congenital cataracts. Associated with skin cancer involvement.
PTMA	PTMA enables DNA-binding transcription factor binding and histone binding activities. It plays a role in the negative regulation of apoptosis and is located in the cytosol and nucleoplasm. PTMA may be involved in skin cancer progression by influencing cell survival mechanisms and gene expression regulation.
RPS20	RPS20 encodes a ribosomal protein part of the 40S subunit, involved in protein synthesis. It belongs to the S10P family and is located in the cytoplasm. Co-transcribed with small nucleolar RNA gene U54. Multiple pseudogenes exist. Related to skin cancer due to effects on cellular protein synthesis regulation.
MMP1	MMP1 encodes matrix metalloproteinase involved in extracellular matrix breakdown. Functions include tissue remodeling and disease processes like arthritis, metastasis, and skin cancer progression. It breaks down interstitial collagens types I, II, III. Located on chromosome 11, it is associated with COPD. Alternative splicing produces multiple isoforms.
SH3BGRL3	SH3BGRL3 is involved in cytoskeleton organization and is located in cytosol, nuclear body, and ruffle membrane. It is associated with skin cancer, potentially influencing cell structure and signaling pathways contributing to tumorigenesis.
RPL15	RPL15 encodes a ribosomal protein in the 60S subunit, linked to protein synthesis. It shows elevated expression in esophageal and gastric tumors, suggesting involvement in cancer. RPL15 deletion is noted in Diamond-Blackfan anemia. Multiple pseudogenes exist throughout the genome.
MYH9	MYH9 encodes non-muscle myosin IIA heavy chain, involved in cytokinesis, cell motility, cell shape maintenance. Mutations linked to sensorineural deafness, Epstein syndrome, Alport syndrome with macrothrombocytopenia, Sebastian syndrome, Fechtner syndrome, macrothrombocytopenia. Associated with skin cancer risk.
GJA1	GJA1 encodes a connexin protein forming gap junctions, facilitating intercellular communication. Mutations linked to oculodentodigital dysplasia, craniometaphyseal dysplasia, heart malformations. Implicated in skin cancer via disrupted cellular communication, contributing to tumor progression.
ITM2B	ITM2B encodes a transmembrane protein processed by proteases to produce a peptide inhibiting beta-amyloid deposition. Mutations causing peptide extension link to familial British and Danish dementia. In skin cancer, altered amyloid pathways may influence tumor progression.
PPIA	PPIA encodes a peptidyl-prolyl cis-trans isomerase involved in protein folding, cyclosporin A-mediated immunosuppression, and HIV virion formation. Its role in skin cancer may involve interactions with cellular pathways affecting cell proliferation and apoptosis. PPIA has multiple pseudogenes on different chromosomes and binds cyclosporin. Studies suggest an impact on tumor progression and immune response regulation.
RPL14	RPL14 encodes a ribosomal protein part of the 60S subunit in ribosomes, essential for protein synthesis. It belongs to the L14E family, featuring a bZIP-like domain, and is cytoplasmic. The gene has polymorphic GCT repeats causing alanine stretches. Transcript variants exist, all encoding the same protein. Multiple pseudogenes are dispersed in the genome. RPL14's role in ribosome assembly may link it to cellular processes implicated in skin cancer.
UBC	UBC gene encodes ubiquitin C, a polyubiquitin precursor involved in ubiquitination. Ubiquitination affects protein degradation, DNA repair, cell cycle, kinase modification, endocytosis, and cell signaling. Alterations in ubiquitination pathways are linked to skin cancer development, impacting cellular processes like apoptosis and proliferation.
RPL5	RPL5 encodes a ribosomal protein part of the 60S subunit, binding 5S rRNA to form 5S RNP. It facilitates 5S rRNA transport to the nucleolus for ribosome assembly and may inhibit tumorigenesis by activating tumor suppressors and downregulating oncoproteins. Mutations are linked to Diamond-Blackfan Anemia. Co-transcribed with snoRNA U21, RPL5 has dispersed pseudogenes.
CD44	CD44 is a cell-surface glycoprotein involved in cell adhesion and migration. It acts as a receptor for hyaluronic acid, osteopontin, collagens, and MMPs. The gene is implicated in lymphocyte activation, recirculation, hematopoiesis, and tumor metastasis. CD44 undergoes alternative splicing, creating diverse isoforms linked to tumor metastasis, including skin cancer.
AHNAK	AHNAK encodes a large scaffold protein involved in cell structure, migration, and tumor metastasis. It may regulate cardiac calcium channels and blood-brain barrier formation. A 17 kDa isoform influences the alternative splicing of AHNAK. This gene is associated with skin cancer in humans.
RPL21	RPL21 encodes a ribosomal protein part of the 60S subunit, located in the cytoplasm. Belongs to L21E family. Multiple pseudogenes exist. Implicated in protein synthesis, potential link to skin cancer through ribosome dysfunction.
DSC3	DSC3 encodes a desmocollin protein, part of desmosomes, essential for cell junctions resisting mechanical stress. Located on chromosome 18, mutations link to arrhythmogenic right ventricular dysplasia-11. Reduced DSC3 expression occurs in various cancers, including skin cancer. Alternative splicing generates multiple transcripts.
CNFN	CNFN gene is involved in keratinization, located in the cornified envelope. It may play a role in skin barrier function and is potentially linked to skin cancer development due to its involvement in epidermal differentiation and cell proliferation.
CD24	CD24 encodes a sialoglycoprotein on granulocytes and B cells, modulating growth and differentiation. It produces a 32 amino acid peptide linked to the cell surface via GPI anchor. Correctly located on chromosome 6, it has pseudogenes on chromosomes 1, 15, 20, and Y. Alternative splicing yields multiple transcripts. Associated with skin cancer.
CFL1	CFL1 encodes a protein that modulates actin dynamics by binding and depolymerizing F-actin and inhibiting G-actin polymerization. Phosphorylation by LIM kinase enhances Rho-induced actin cytoskeleton reorganization. Involved in actin-cofilin complex translocation from cytoplasm to nucleus, CFL1 plays a role in cellular processes related to skin cancer development.
COL17A1	COL17A1 encodes a transmembrane protein, type XVII collagen, crucial in hemidesmosomes at the dermal-epidermal junction, aiding keratinocyte adhesion. Mutations link to skin conditions like generalized atrophic benign and junctional epidermolysis bullosa. Exists in full length and soluble forms, with the latter derived from proteolytic processing. Related to skin cancer, possibly affecting cellular adhesion and signaling pathways.
HSP90AA1	HSP90AA1 encodes an inducible molecular chaperone protein functioning as a homodimer, facilitating proper folding of target proteins via ATPase activity, influenced by co-chaperones. Variants include multiple isoforms. Implicated in skin cancer through its role in protein stabilization and folding, impacting cell growth and survival pathways.
RPS16	RPS16 encodes a ribosomal protein in the 40S subunit, part of the S9P family, located in the cytoplasm. Multiple pseudogenes exist. It is linked to protein synthesis and associated with skin cancer development in humans.
PKM	PKM encodes pyruvate kinase involved in glycolysis, catalyzing ATP and pyruvate production. It interacts with thyroid hormones, affecting cellular metabolism. PKM binds bacterial Opa protein, suggesting a role in pathogenesis. Alternative splicing produces distinct isoforms. It is implicated in metabolic modulation and may influence skin cancer progression through altered cellular energy dynamics.
NACA	NACA gene encodes a protein forming the nascent polypeptide-associated complex (NAC) with BTF3, blocking signal recognition particle interaction. It prevents protein mistranslocation to the endoplasmic reticulum. NACA is an IgE autoantigen in atopic dermatitis. It has multiple transcript variants and pseudogenes across chromosomes. Associated with skin cancer risk due to its role in protein synthesis regulation.
RPS5	RPS5 encodes a ribosomal protein in the 40S subunit, part of the S7P family, located in the cytoplasm. It shows variable expression in colorectal cancers. No correlation with disease severity is found. Multiple pseudogenes exist in the genome. Its role in skin cancer is under investigation, potentially impacting protein synthesis in cancerous cells.
ALDOA	ALDOA encodes a glycolytic enzyme involved in the reversible conversion of fructose-1,6-bisphosphate. It is part of the class I fructose-bisphosphate aldolase family. Mutations are linked to Glycogen Storage Disease XII and hemolytic anemia. ALDOA is implicated in cancer progression, including skin cancer. Isozymes A, B, and C are differentially expressed. Pseudogenes are located on chromosomes 3 and 10.
H3F3B	H3F3B encodes a replication-independent histone H3, part of the nucleosome structure in eukaryotes. It aids in chromatin organization, impacting gene expression regulation. Alterations in H3F3B are associated with skin cancer development. Pseudogenes exist on chromosomes X, 5, 13, and 17.
S100A16	S100A16 is associated with calcium ion binding and transition metal ion binding. It plays a role in cell envelope organization and skin barrier formation. The gene is found in the cornified envelope, keratohyalin granule, and perinuclear region of the cytoplasm. Its functions may impact processes related to skin cancer development in humans.
TAGLN2	TAGLN2 encodes a protein akin to transgelin, an early marker of smooth muscle differentiation. While its precise function is undetermined, TAGLN2 is considered a tumor suppressor. Variant transcripts encode multiple isoforms, potentially implicating skin cancer involvement.
HLA-C	HLA-C is a class I molecule involved in immune response, presenting peptides. It consists of heavy and beta-2 microglobulin chains. Exons encode structural domains. Polymorphisms affect peptide binding, important in transplantation. HLA-C influences infectious disease outcomes, including malaria, HIV, SARS-CoV, and COVID-19. It has around 6000 alleles.
TRIM29	TRIM29 is part of the TRIM protein family, featuring zinc finger and leucine zipper motifs, potentially forming dimers for nucleic acid binding. It may function as a transcriptional regulatory factor in carcinogenesis and differentiation, and is linked to radiosensitivity suppression, associated with ataxia telangiectasia.
LYPD3	LYPD3 is linked to skin cancer in humans, predicted to enable laminin binding activity, involved in negative regulation of smooth muscle cell apoptotic process. Located in extracellular space, it plays a role in cellular adhesion and signaling, potentially influencing cancer progression.
FAU	FAU gene encodes a fusion protein with ubiquitin-like fubi and ribosomal protein S30, linked to skin cancer. Fubi's function is unknown; S30 is part of the 40S ribosomal subunit with antimicrobial activity. FAU homologous to FBR-MuSV fox sequence; processed post-translationally. FAU pseudogenes present; similar proteins include S27a and L40.
LMNA	LMNA encodes nuclear lamina proteins involved in nuclear stability, chromatin structure, gene expression. Mutations link to Emery-Dreifuss muscular dystrophy, lipodystrophy, limb girdle muscular dystrophy, dilated cardiomyopathy, Charcot-Marie-Tooth disease, Hutchinson-Gilford progeria. Potential role in skin cancer.
SPINK5	SPINK5 encodes a serine protease inhibitor involved in skin and hair morphogenesis, mucous epithelia protection, and possible skin cancer links. Mutations can cause Netherton syndrome, characterized by ichthyosis and atopy. Located on chromosome 5, it undergoes alternative splicing for transcript variants.
SPRR2E	SPRR2E encodes a small proline-rich protein in the epidermal differentiation complex on chromosome 1q21. It is part of the cornified cell envelope in terminally differentiated stratified squamous epithelia, serving as a barrier against external factors. SPRR2 genes (A-G) are homogenized by gene conversion, differing less in protein structure.
RPL22	RPL22 encodes a cytoplasmic ribosomal protein part of the 60S subunit, binds Epstein-Barr virus RNAs. It maps to chromosome 1p36.3-p36.2, not involved in AML1 fusions. Important for protein synthesis, has multiple pseudogenes. Associated with skin cancer, alternative polyA signals exist.
KRT2	KRT2 encodes a type II cytokeratin protein in keratin gene family. It is expressed in epidermal keratinocytes, especially in the upper spinous layer. Mutations are linked to bullous congenital ichthyosiform erythroderma. Type II cytokeratins are located on chromosome 12q12-q13. Research indicates potential involvement in skin cancer development due to its role in epithelial tissue differentiation.
CST3	CST3 encodes a cysteine protease inhibitor in human fluids, providing protective functions. Located on chromosome 20, it's the most abundant extracellular inhibitor. Mutations link to amyloid angiopathy. CST3 expression is reduced in vascular diseases like atherosclerosis and aneurysms. It also inhibits herpes simplex virus replication. Alternative splicing generates multiple transcripts encoding the same protein.
DSG3	DSG3 encodes a desmoglein family protein involved in cell adhesion within desmosomes. Located on chromosome 18, it interacts with epithelial cells. DSG3 is linked to autoimmune blistering disease pemphigus vulgaris and implicated in skin cancer progression through altered cell adhesion and signaling pathways.
CLCA2	CLCA2 encodes a member of calcium-activated chloride channel regulator family involved in chloride transport. Protein is processed into N- and C-terminal fragments. Upregulated by tumor suppressor p53 upon DNA damage. In breast cancer, downregulation inhibits migration and invasion, promotes mesenchymal-to-epithelial transition. Related to skin cancer.
RPSA	RPSA encodes 67 kD laminin receptor, involved in cell adhesion, differentiation, and metastasis. Laminin receptors interact with cell surface receptors, including integrins. RPSA transcript levels are elevated in colon carcinoma and lung cancer, correlating with invasive phenotype. Multiple pseudogenes exist due to retropositional events. Two transcript variants encode the same protein. Associated with skin cancer through similar mechanisms of cell interaction and metastasis.
DSG1	DSG1 is part of the desmoglein protein subfamily, involved in desmosome cell-cell junctions. Located on chromosome 18, DSG1 is linked to autoimmune skin diseases like pemphigus foliaceus and associated with palmoplantar keratoderma, erythroderma. Alterations in DSG1 may contribute to skin cancer susceptibility due to its role in cell adhesion under mechanical stress.
RPS9	RPS9 is a ribosomal protein part of the 40S subunit, involved in protein synthesis in the cytoplasm. It belongs to the S4P family. Variable expression noted in colorectal cancers, with pseudogenes dispersed in the genome. No correlation with cancer severity. Studies may explore its role in skin cancer.
NDRG1	NDRG1 is a cytoplasmic protein from the N-myc downregulated gene family, part of the alpha/beta hydrolase superfamily. It plays roles in stress, hormone responses, cell growth, differentiation, and p53-mediated caspase activation and apoptosis. Mutations cause Charcot-Marie-Tooth disease type 4D and its expression may indicate cancer prognosis. Multiple isoforms exist due to alternative splicing.
AC090498.1	AC090498.1 is a non-coding RNA associated with regulatory functions in cellular processes. It is implicated in melanoma progression. Studies suggest its role in gene expression modulation affecting cancer proliferation and metastasis. Research continues to explore its potential as a biomarker for early detection and therapeutic target in skin cancer treatment.
GRN	GRN encodes progranulin, a precursor for granulins involved in cell growth regulation. Granulins are glycosylated peptides derived from progranulin, impacting cell growth as inhibitors or stimulators. Progranulin is linked to skin cancer, influencing tumorigenesis, development, and wound healing. Different granulin peptides such as granulin A and B have distinct regulatory functions. Granulins are associated with diverse cellular processes, including cancer progression in skin cells.
TXN	TXN gene encodes a protein involved in redox reactions and reversible S-nitrosylation of cysteines, responding to intracellular nitric oxide. The protein is cytoplasmic and functions as a homodimer. TXN has two transcript variants encoding different isoforms. Associated with skin cancer susceptibility.
HSPA8	HSPA8 encodes a heat shock protein 70 family member, involved in protein folding and cellular transport. It functions as a chaperone and ATPase, aiding clathrin-coated vesicle disassembly. HSPA8 has alternatively spliced variants. It is associated with cellular stress responses, potentially influencing skin cancer progression.
TGFBI	TGFBI encodes a protein with an RGD motif that binds type I, II, and IV collagens, influencing cell adhesion via integrins. It plays roles in cell-collagen interactions and endochondrial bone formation. Induced by TGF-beta, it inhibits cell adhesion. Mutations link to corneal dystrophy. Implicated in skin cancer due to effects on cellular adhesion and extracellular matrix interactions.
CTSB	CTSB encodes a lysosomal cysteine protease involved in protein turnover and amyloid precursor protein processing. Overexpression is linked to esophageal adenocarcinoma and other tumors, including skin cancer. CTSB also cleaves SARS-CoV-2 spike protein. Multiple transcript variants and pseudogenes exist for CTSB.
SPRR2D	SPRR2D is involved in female gonad development, response to estradiol, and is located in cytoplasm. It may be associated with skin cancer development and progression in humans due to its role in cellular response mechanisms.
HLA-DRA	HLA-DRA is an HLA class II alpha chain paralogue involved in immune response. It forms a heterodimer with a beta chain, presenting pathogen-derived peptides to T cells. Expressed on antigen-presenting cells, it lacks polymorphisms in its peptide-binding region and acts as the sole alpha for DRB1, DRB3, DRB4, and DRB5. The gene has five exons encoding different structural regions. Its role in skin cancer involves immune recognition and response regulation.
ACTN4	ACTN4 encodes a nonmuscle alpha actinin isoform involved in binding actin to membranes, found in microfilament bundles and adherens-type junctions. It is part of the spectrin gene superfamily. ACTN4 is linked to metastatic processes in cancer and mutations are associated with focal segmental glomerulosclerosis.
RPS21	RPS21 encodes a ribosomal protein part of the 40S subunit, involved in protein synthesis. It is located in the cytoplasm and belongs to the S21E family. Alternative splice variants exist but are unverified. Multiple processed pseudogenes are dispersed in the genome. RPS21 may be associated with human skin cancer through its role in ribosomal function disruption.
EIF1	EIF1 enables ribosomal small subunit binding and translation initiation factor activity, contributing to translational initiation regulation. It is located in the cytoplasm and nucleus, forming part of the eukaryotic 43S and 48S preinitiation complexes and the multi-eIF complex. It is associated with skin cancer due to its role in protein synthesis and cell proliferation.
CTSD	CTSD encodes a peptidase involved in protein turnover, hormone activation, and growth factor regulation. It forms a mature enzyme with pepsin-like activity. Mutations are linked to neuronal ceroid lipofuscinosis-10, breast cancer, Alzheimer's disease, and potentially skin cancer due to its role in cell regulation processes.
ARPC2	ARPC2 encodes the p34 subunit of the Arp2/3 protein complex involved in actin polymerization. Its role in skin cancer is under study. Two characterized and additional uncharacterized splice variants exist.
CALML3	CALML3 is involved in calcium ion binding, potentially affecting cellular signaling. It is associated with extracellular exosomes. Research suggests a role in skin cancer development, possibly through regulation of cell proliferation and differentiation. CALML3 expression may influence tumor progression and metastasis.
KLK7	KLK7 encodes a serine protease in the kallikrein subfamily, involved in carcinogenesis and potential as a cancer biomarker. It is regulated by steroid hormones and elevated in various cancers. KLK7 participates in the cleavage of amyloid precursor protein and alpha-synuclein, linked to Alzheimer's and Parkinson's diseases. Located on chromosome 19, it undergoes alternative splicing, producing multiple transcript variants.
CALM1	CALM1 encodes a calmodulin protein, part of the EF-hand calcium-binding family. It modulates cardiac ion channels. Two pseudogenes are on chromosomes 7 and X. Multiple transcript variants exist. CALM1 mutations are linked to ventricular tachycardia and may influence skin cancer via calcium signaling pathways.
GNAS	GNAS is involved in complex imprinted expression, producing various transcripts via alternative promoters and splicing. It affects signal transduction through G-protein alpha subunit, linking receptor-ligand interactions with adenylyl cyclase activation. Mutations associate with conditions like pseudohypoparathyroidism, Albright hereditary osteodystrophy, McCune-Albright syndrome, and skin cancer. GNAS transcripts include DMRs, influencing imprinting and expression. It generates antisense noncoding RNAs, potentially regulating imprinting, and a structurally unrelated protein, Alex.
DYNLL1	DYNLL1 encodes a light chain protein within cytoplasmic dynein complexes, involved in intracellular transport. It interacts with neuronal nitric oxide synthase, inhibiting its activity by destabilizing its dimer form. This regulation affects nitric oxide synthase activity and various biological processes. DYNLL1 has alternate transcriptional splice variants. It is associated with skin cancer development in humans.
FLG	FLG encodes profilaggrin, a structural protein in the skin. Mutations can lead to ichthyosis vulgaris and increased risk of atopic dermatitis. FLG dysfunction is linked to impaired skin barrier, facilitating carcinogen penetration, contributing to skin cancer development. Variants in FLG affect skin moisture retention and protection against environmental factors.
FLNA	FLNA encodes an actin-binding protein involved in cytoskeletal remodeling, cell shape, and migration. It interacts with integrins and receptor complexes. Mutations cause syndromes like PVNH1, OPD1, FMD, and MNS. It has roles in cancer cell migration and metastasis. Two isoforms exist.
DST	DST encodes adhesion junction plaque proteins in the plakin family. Isoforms anchor intermediate filaments to cytoskeletons in tissues. Variants are found in neural, muscle, and epithelial tissues. Defects lead to skin blistering, neurodegeneration, and potential skin cancer connections. Alternatively spliced transcripts exist, but some remain undefined.
SLC2A1	SLC2A1 encodes a glucose transporter integral to the blood-brain barrier and cell membrane. It also acts as a receptor for HTLV I and II. Mutations are linked to paroxysmal exertion-induced dyskinesia. In skin cancer, altered glucose transport may affect tumor metabolism and growth.
PSAP	PSAP encodes a protein involved in surfactant homeostasis and pathogen defense. Mutations link to pulmonary fibrosis. Associated with skin cancer, it impacts lipid and microorganism surface carbohydrate binding. Alternate splicing produces transcript variants.
EIF4G2	EIF4G2 encodes a protein involved in translation initiation, forming inactive complexes that repress translation. It shares similarities with eIF4G, binding eIF4A and eIF3, but lacks eIF4E binding. Initiation occurs at non-AUG codon GUG. It may play a role in skin cancer mechanisms, possibly affecting translation regulation. Variants exist due to alternative splicing.
EEF1B2	EEF1B2 encodes a translation elongation factor facilitating aminoacylated tRNA transfer to ribosomes. It acts as a guanine nucleotide exchange factor. Alternative splicing produces three transcript variants differing in the 5' UTR. Studies link EEF1B2 to skin cancer pathogenesis in humans.
FGFBP1	FGFBP1 encodes a fibroblast growth factor carrier protein involved in cell proliferation, differentiation, and migration. It binds fibroblast growth factors, enhancing their effects. FGFBP1 is linked to tumor growth, acting as an angiogenic switch, and is associated with cancers like pancreatic and colorectal adenocarcinoma. A pseudogene exists on chromosome 4.
LGALS1	LGALS1 encodes a beta-galactoside-binding protein in galectin family. Implicated in cell-cell, cell-matrix interactions, it may act as a negative growth factor impacting cell proliferation. Linked to skin cancer through modulation of cellular interactions and signaling pathways, influencing tumor growth and metastasis.
ITGA6	ITGA6 encodes an integrin alpha chain involved in cell adhesion and signaling. It forms integrins with beta 1 or beta 4 subunits, interacting with laminin family proteins. The alpha 6 beta 4 integrin is linked to tumorigenesis, and alpha 6 beta 1 integrin may modulate erbB2/HER2 signaling. Multiple transcript variants arise from alternative splicing.
MYL12B	MYL12B encodes a regulatory light chain involved in nonmuscle myosin II activity. Phosphorylation enhances MgATPase activity and filament assembly. Altered MYL12B expression or function may contribute to skin cancer development by affecting cell motility and adhesion.
TPI1	TPI1 encodes an enzyme for the isomerization of G3P and DHAP in glycolysis and gluconeogenesis. Mutations link to triosephosphate isomerase deficiency. Pseudogenes on chromosomes 1, 4, 6, 7. Alternative splicing creates multiple variants. Studies suggest TPI1's involvement in metabolic pathways influencing skin cancer vulnerability.
RPL10A	RPL10A encodes a ribosomal protein in the 60S subunit, part of the L1P family, located in the cytoplasm. Downregulated by cyclosporin-A in the thymus and in neural precursor cells during development. Associated with processed pseudogenes across the genome. Linked to skin cancer through protein synthesis regulation disruptions, affecting cellular growth and function in cancerous skin cells.
TMEM45A	TMEM45A is located in membrane and is implicated in skin cancer. It may influence cell proliferation and survival. Studies suggest a role in tumor progression and resistance. TMEM45A could be a target for therapeutic intervention in skin cancer. Expression levels may correlate with cancer severity. Further research is necessary to understand its mechanisms in oncogenesis.
BTF3	BTF3 encodes a transcription factor interacting with RNA polymerase IIB, essential for transcription initiation. It has multiple transcript variants and pseudogenes. Research suggests links to skin cancer through regulation of cell proliferation and apoptosis. Studies indicate its role in tumorigenesis and potential as a therapeutic target.
DSTN	DSTN encodes an actin depolymerizing protein in the ADF family, enhancing actin turnover by severing F-actin and binding G-actin. It has two transcript variants for different isoforms. DSTN is associated with skin cancer due to its role in actin cytoskeleton dynamics, affecting cell motility and growth.
RTN4	RTN4 is part of the reticulon gene family, linked to endoplasmic reticulum, impacting neuroendocrine secretion and membrane trafficking. It encodes a neurite outgrowth inhibitor, potentially affecting central nervous system regeneration. Various isoforms exist due to alternative splicing and promoter usage. RTN4's role in skin cancer involves its inhibitory effect on cellular processes, possibly influencing tumor progression or metastasis.
HNRNPA2B1	HNRNPA2B1 is part of the hnRNP A/B subfamily, influencing pre-mRNA processing, mRNA metabolism, and transport. It binds to RNA with quasi-RRM domains and shuttles between nucleus and cytoplasm. Alternative splicing results in different isoforms. Associated with skin cancer.
LAD1	LAD1 encodes collagen XVII, a transmembrane protein in hemidesmosomes, crucial for keratinocyte adhesion at the dermal-epidermal junction. Mutations link to epidermolysis bullosa. It exists in full-length and soluble forms. Associated with skin cancer due to its role in structural integrity and cell adhesion.
ATP1A1	ATP1A1 encodes the alpha 1 subunit of Na+/K+-ATPase, an enzyme crucial for ion gradients across plasma membranes. It plays roles in osmoregulation, sodium-coupled transport, and nerve/muscle excitability. Variants and isoforms affect these functions, linked to skin cancer susceptibility.
SERPINB3	SERPINB3 is involved in cysteine-type endopeptidase inhibition, protease binding, and virus receptor activity. It participates in autocrine and paracrine signaling and regulates protein metabolism. It is located in cytoplasmic vesicles, cytosol, and extracellular exosomes. This gene's dysregulation has been associated with skin cancer progression and metastasis.
PRDX1	PRDX1 encodes an antioxidant enzyme reducing peroxides; involved in cell protection, antiviral activity of CD8(+) T-cells, and cancer progression. Four transcript variants exist. Implicated in skin cancer through regulation of oxidative stress and cell proliferation.
COL6A1	COL6A1 encodes the alpha1(VI) chain of type VI collagen, a structural component of microfibrils in the extracellular matrix. Mutations in COL6A1 are linked to Bethlem myopathy and may play a role in skin cancer by affecting tissue integrity and cellular interaction in the skin.
ATP5E	ATP5E encodes the epsilon subunit of mitochondrial ATP synthase's catalytic core, participating in ATP synthesis via oxidative phosphorylation. It includes read-through transcripts with SLMO2 gene exons and has pseudogenes on chromosomes 4 and 13. Mutations in ATP5E may affect mitochondrial function and are potentially related to skin cancer development.
PPDPF	PPDPF is involved in cell differentiation, TORC1 signaling, and liver development. It is located in the mitochondrion. It has implications in skin cancer due to its role in cell differentiation and signaling pathways.
TYMP	TYMP encodes angiogenic factor promoting angiogenesis and endothelial cell growth. It shows target cell specificity for endothelial cells. Mutations link to mitochondrial neurogastrointestinal encephalomyopathy. Related to skin cancer through its role in angiogenesis and potential impact on tumor vascularization. Multiple transcript variants exist.
CD63	CD63 is a tetraspanin family member involved in signal transduction affecting cell development, activation, growth, and motility. It functions as a cell surface glycoprotein and complexes with integrins. CD63 is linked to blood platelet activation and Hermansky-Pudlak syndrome. It is also associated with tumor progression and has multiple transcript variants due to alternative splicing.
EIF5A	EIF5A facilitates U6 snRNA binding, participates in cellular virus response, apoptosis regulation, and TNF signaling. Located in annulate lamellae, cytoplasm, and nucleus; part of nuclear pore. Associated with colorectal cancer and implicated in skin cancer studies.
YWHAQ	YWHAQ encodes a 14-3-3 protein involved in signal transduction via binding phosphoserine-containing proteins. It is highly conserved across species, with 99% identity to mouse and rat. YWHAQ is upregulated in amyotrophic lateral sclerosis and has a polymorphic 5' UTR tandem repeat. Associated with skin cancer through cellular signaling pathways.
PGK1	PGK1 encodes a glycolytic enzyme converting 1,3-diphosphoglycerate to 3-phosphoglycerate, acts as polymerase alpha cofactor, and is secreted by tumor cells to aid angiogenesis by reducing plasmin disulfide bonds, releasing angiostatin. PGK1 is a moonlighting protein linked to hemolytic anemia and neurological impairment. Pseudogenes exist on chromosomes 19, 21, and X. Involved in skin cancer pathogenesis.
HLA-E	HLA-E is part of HLA class I molecules, composed of a heavy chain and beta-2 microglobulin. It binds peptides from class I molecules' leader sequences. The gene has 8 exons, encoding various domains including peptide-binding and transmembrane regions. HLA-E plays a role in immune response regulation and is linked to skin cancer susceptibility in humans.
IFITM3	IFITM3, part of the interferon-induced transmembrane protein family, restricts entry of viruses like influenza A, Ebola, and SARS-CoV-2. Besides its antiviral role, IFITM3 is involved in cellular processes linked to skin cancer, affecting cell proliferation and immune response modulation.
RPS26	RPS26 encodes a ribosomal protein in the 40S subunit, part of the S26E family. Mutations link to Diamond-Blackfan anemia, a rare disorder potentially associated with cancer risk. Pseudogenes are dispersed throughout the genome. Its role in protein synthesis may implicate it in skin cancer pathogenesis.
IGFBP4	IGFBP4 encodes a protein part of the IGFBP family, containing IGFBP and thyroglobulin type-I domains. It binds IGF I and II, circulating in both glycosylated and non-glycosylated forms. This binding extends IGFs' half-life and modifies their receptor interactions. IGFBP4 is linked to skin cancer development by affecting IGF pathways involved in cell growth and survival.
OAZ1	OAZ1 encodes antizyme 1, part of the ornithine decarboxylase antizyme family. It regulates polyamine levels by inhibiting ornithine decarboxylase (ODC) and polyamine uptake. High polyamines enhance antizyme expression via ribosomal frameshifting. OAZ1 mRNA has two AUGs, producing isoforms with distinct localization. It may influence skin cancer by affecting cell growth and proliferation through polyamine regulation.
NPM1	NPM1 encodes a phosphoprotein involved in centrosome duplication, protein chaperoning, and cell proliferation. It shuttles between nucleolus, nucleus, and cytoplasm, chaperoning ribosomal proteins and histones. It sequesters tumor suppressor ARF in nucleolus. Mutations link to acute myeloid leukemia; potential skin cancer involvement. Numerous pseudogenes exist.
LCE3D	LCE3D is involved in keratinization, a process crucial for skin barrier function. It is located in the cytosol and associated with skin cancer. Mutations may disrupt normal skin cell differentiation, contributing to tumorigenesis. LCE3D plays a role in maintaining skin integrity and may be a target for therapeutic interventions in skin cancer treatment.
FXYD3	FXYD3 encodes a cell membrane protein involved in regulating Na+/K+ ATPase activity, affecting ion-pumps and ion-channels. It is implicated in tumor progression, including skin cancer. Alternative splicing leads to various transcript variants encoding different isoforms.
MT2A	MT2A is a metallothionein family gene, encoding cysteine-rich proteins that bind divalent heavy metals. These proteins regulate metal homeostasis, detoxification, and act as antioxidants. MT2A influences intracellular zinc levels, impacting apoptotic and autophagy pathways. Polymorphisms in MT2A are linked to increased skin cancer risk.
COL6A2	COL6A2 encodes an alpha chain of type VI collagen, essential in connective tissues. It contains von Willebrand Factor type A domains that bind extracellular matrix proteins. Mutations link to Bethlem myopathy and Ullrich muscular dystrophy. It may have implications in skin cancer due to its role in matrix organization. Three transcript variants exist.
POLR2L	POLR2L encodes a subunit of RNA polymerase II, responsible for mRNA synthesis in eukaryotes. The subunit contains an atypical zinc-binding domain with conserved cysteines. It may be shared by DNA-directed RNA polymerases I and III. POLR2L's role in transcription links it to skin cancer development by influencing gene expression patterns pivotal for cell proliferation and repair mechanisms.
CD59	CD59 encodes a glycoprotein regulating complement-mediated cell lysis and lymphocyte signal transduction. It inhibits the complement membrane attack complex by binding C8/C9, preventing osmolytic pore formation. CD59 influences T cell activation pathways. Mutations lead to CD59 deficiency, causing hemolytic anemia, thrombosis, and cerebral infarction. Multiple transcript variants exist.
HNRNPK	HNRNPK is part of ubiquitously expressed hnRNPs, RNA binding proteins that complex with hnRNA, influencing pre-mRNA processing, mRNA metabolism, and transport. It binds to poly(C) and shuttles between nucleus and cytoplasm. Located in nucleoplasm, it has KH domain repeats. HNRNPK plays a role in cell cycle progression and has alternatively spliced variants. Linked to skin cancer, it affects cellular processes related to tumor development.
RPL35	RPL35 encodes a ribosomal protein part of the 60S subunit in the cytoplasm, involved in protein synthesis. It belongs to the L29P ribosomal protein family. The gene has multiple processed pseudogenes distributed across the genome. RPL35 may have implications in skin cancer due to its role in protein synthesis and cell growth regulation.
TMBIM6	TMBIM6 is involved in endoribonuclease inhibitor activity and ubiquitin protein ligase binding. It negatively regulates intrinsic apoptotic signaling, macromolecule metabolism, and calcium ion transport into cytosol. Located in the endoplasmic reticulum membrane, it serves as a biomarker for cervical squamous cell carcinoma and prostate carcinoma. Potentially implicated in skin cancer due to its role in apoptotic signaling and cellular stress response.
HSP90AB1	HSP90AB1 encodes a constitutive heat shock protein involved in signal transduction, protein folding, and degradation. It plays a role in apoptosis and inflammation. Alternative splicing results in multiple variants. Pseudogenes exist on various chromosomes. Linked to skin cancer through its involvement in cellular stress responses and protein homeostasis.
